CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration

Conclusions: The expression of CXCL5 is elevated in pancreatic cancer cells. High CXCL5 expression is positively correlated with poor survival and the increased infiltration of several types of immune suppressive cells. Thus, CXCL5 could be a promising therapeutic target for PDAC immunotherapy.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Ronghua Zhang, Qiaofei Liu, Junya Peng, Mengyi Wang, Tong Li, Jingkai Liu, Ming Cui, Xiang Zhang, Xiang Gao, Quan Liao, Yupei Zhao Tags: Research Paper Source Type: research